ATONF yields 2.74% · JNJ yields 2.14%● Live data
📍 JNJ pulled ahead of the other in Year 5
Combined, ATONF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ATONF + JNJ for your $10,000?
Anton Oilfield Services Group, an investment holding company, provides oilfield engineering and technical services for oil companies in the People's Republic of China and internationally. It operates through four segments: Inspection Services, Oilfield Management Services, Oilfield Technical Services, and Drilling Rig Services. The company offers inspection and repair, intelligent monitoring, and digital and intelligent management services of various equipment and facilities for the operation of customers' oil and gas field equipment, facilities, and assets; management general contracting, including reservoir support, operation management, production operation, logistics, and third-party service provider management, as well as health, safety, and environment services; capacity construction; oilfield development management; and oilfield operation and maintenance services, such as engineering contracting, commissioning, and operation and maintenance management services for oilfield assets of oil companies. It also provides geological, drilling, well completion, and stimulation technology services, as well as asset leasing services; and drilling and well workover services that require drilling rigs. In addition, the company manufactures rod casings; and provides construction services. Anton Oilfield Services Group was founded in 1999 and is based in Beijing, China. Anton Oilfield Services Group is a subsidiary of Pro Development Holdings Corp.
Full ATONF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.